Journal article

Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial

Alistair Nichol, Craig French, Lorraine Little, Jeffrey Presneill, D James Cooper, Samir Haddad, Jacques Duranteau, Olivier Huet, Markus Skrifvars, Yaseen Arabi, Rinaldo Bellomo

Trials | BMC | Published : 2015

Grants

Awarded by Australian National Health and Medical Research Council Project


Awarded by Victorian Transport Accident Commission


Funding Acknowledgements

EPO-TBI is funded by the Australian National Health and Medical Research Council Project (project grant ID 545901), and the Victorian Transport Accident Commission (project grant ID D162 - formerly, the Victorian Neurotrauma Initiative). The cost of Epoetin alfa was reimbursed to hospital pharmacy departments by using project grant funds. Neither funding agencies nor the manufacturer of Epoetin alfa had any role in the trial design, data collection or analysis. EPO-TBI trial is coordinated by the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia and endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Irish Critical Care Trials Group. The members of Management Committee are listed in Appendix 3